February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|What's Hot in HIV Treatment|
|Nutrition and Exercise Tips From HIV Experts at ICAAC 2014|
|A "Bad Year" for HIV Cure Research? Experts Mix Realism and Hope|
|Medicines Patent Pool Signs With 6 Manufacturers to Develop Generic Tenofovir Alafenamide|
|HIV Reservoir Discovered Within Lungs|
|BMS-986001 Bone, Metabolic Data Compare Well to Tenofovir Through 48 Weeks|